Patents by Inventor Zhenguo WEN

Zhenguo WEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220088232
    Abstract: Provided are anti-PD-L1 diabodies, imaging agents, methods and kits for determination of the distribution and expression levels of PD-L1 in an individual having a disease or condition. Anti-PD-L1 diabody agents, and methods for treating diseases or disorders are also provided.
    Type: Application
    Filed: January 17, 2020
    Publication date: March 24, 2022
    Applicant: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping CHEN, Zhenguo WEN, Liqun LUO, Qianyong LIU
  • Publication number: 20210309745
    Abstract: The present application provides methods, imaging agents and kits for determination of the distribution and expression levels of an immune checkpoint ligand (such as PD-L1 or a PD-L1 like ligand) in an individual having a disease or condition. Anti-PD-L1 antibody agents are also provided.
    Type: Application
    Filed: July 26, 2018
    Publication date: October 7, 2021
    Applicant: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping CHEN, Liqun LUO, Zhenguo WEN, Qianyong LIU
  • Publication number: 20210213145
    Abstract: Provided are methods, imaging agents and kits for determination of the distribution and expression levels of an immune checkpoint ligand (such as PD-L1 or a PD-L1 like ligand) in an individual having a disease or condition. Anti-PD-L1 antibody agents are also provided.
    Type: Application
    Filed: May 31, 2019
    Publication date: July 15, 2021
    Applicant: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping CHEN, Liqun LUO, Zhenguo WEN, Qianyong LIU